Clinical Trials Directory

Trials / Unknown

UnknownNCT03629132

PRP Prevents Recurrence of Intrauterine Adhesions

Platelet-rich Plasma(PRP) Prevents Recurrence of Intrauterine Adhesions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Yanhong Deng · Academic / Other
Sex
Female
Age
20 Years – 37 Years
Healthy volunteers
Not accepted

Summary

Effect of platelet-rich plasma (PRP) on uterine scar fibrosis, endometrial receptivity and pregnancy outcome in patients with severe intrauterine adhesions

Detailed description

1. Inclusion criteria: patients with intrauterine adhesions (AFS score \>9 points); age 21 to 40 years old, with fertility requirements. 2. Study design:prospective, randomized controlled cohort study, patients with intrauterine adhesions were randomized into two groups, the control group and the intervention group (intraoperative and postoperative 1 week postoperative PRP). The surgical procedures and postoperative medication regimens were the same. 3. Compare the biochemical pregnancy rate, clinical pregnancy rate, abortion rate and live birth rate after hysteroscopic resection in PRP group and control group, and explore the effect of PRP on pregnancy outcome after intrauterine adhesion.

Conditions

Interventions

TypeNameDescription
PROCEDUREPlatelet-rich plasmaPlatelet-rich plasma intrauterine injection
PROCEDUREgelSelf-crosslinking sodium hyaluronate gel intrauterine injection

Timeline

Start date
2018-08-15
Primary completion
2019-08-01
Completion
2019-12-30
First posted
2018-08-14
Last updated
2018-08-14

Source: ClinicalTrials.gov record NCT03629132. Inclusion in this directory is not an endorsement.